ASCVD: atherosclerotic cardiovascular disease
Obesity is a major risk factor for T2DM [6, 7]
Studies suggest it may raise GH levels by 2001000% and increase mean plasma IGF-1 concentrations by 1.53 fold, with effects persisting for 68 days under experimental conditions
Blue Capsule (CHELA-MIN): Magnesium bisglycinate (magnesium amino acid chelate), calcium bisglycinate (calcium amino acid chelate), magnesium oxide, potassium chloride, calcium carbonate, zinc bisglycinate (zinc amino acid chelate), manganese bisglycinate (manganese amino acid chelate), ferrous bisglycinate (iron amino acid chelate), sodium selenite, chromium (III) chloride, copper bisglycinate (copper amino acid chelate), potassium iodide, bulking agent (microcrystalline cellulose), anti-caking agent (magnesium stearate), capsule (gelatin, colours: E132, E171)